Diabetes and obesity can damage the liver to the point of failure – but few people know their risk of developing liver disease

Liver disease is frighteningly common worldwide. Metabolic dysfunction-associated steatotic liver disease, or MASLD, is an umbrella term describing conditions related to a buildup of fat in the liver. Formerly known…

Global diabetes cases on pace to soar to 1.3 billion people in the next 3 decades, new study finds

The Research Brief is a short take about interesting academic work. The big idea The number of people living with diabetes worldwide is on pace to more than double in…

Drugs that melt away pounds still present more questions than answers, but Ozempic, Wegovy and Mounjaro could be key tools in reducing the obesity epidemic

In the past five years, several new drugs have been brought to market that could lead to a profound, if not revolutionary, change in how health care providers – and…